Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a

Graham Mazereeuw, Nathan Herrmann, Hongbin Xu

  • 1Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, Room FG08, Toronto, ON M4N 3M5, Canada. Krista.Lanctot@sunnybrook.ca.

Insights

Certain platelet-activating factors (PAFs) are linked to cognitive decline in coronary artery disease (CAD) patients, especially those with depression. Specific PAFs correlate with poorer cognitive performance, while one may offer a protective effect.

Area of Science:

  • Lipidomics
  • Neuroscience
  • Cardiology

Background:

  • Coronary artery disease (CAD) patients face heightened risk of cognitive decline, particularly when experiencing major depression.
  • Inflammatory processes, common in CAD and depression, are implicated in neurodegeneration and cognitive impairment.
  • Platelet-activating factors (PAFs) are emerging as critical lipid mediators potentially linking inflammation, neurodegeneration, and cognitive decline in CAD.

Purpose of the Study:

  • To investigate the association between various platelet-activating factors (PAFs) and cognitive performance in patients with coronary artery disease (CAD).
  • To explore these relationships further in a subgroup of CAD patients with major depression.

Main Methods:

  • Cross-sectional study involving 24 CAD patients (70.8% male, mean age 60.3 years).
  • Cognitive performance assessed using a standardized battery, with global cognitive performance derived from summary z scores.
  • Plasma PAF levels analyzed using electrospray ionization mass spectrometry (precursor ion scan).

Main Results:

  • Elevated PAF PC(O-18:0/2:0) abundance correlated with poorer global cognitive performance in CAD patients (r=-0.45, P=0.03).
  • In the major depressed subgroup, PAF PC(O-18:0/2:0), PC(O-16:0/2:0), and lyso-PAF PC(O-16:0/0:0) were associated with poorer cognitive performance.
  • Higher PAF PC(O-19:5/2:0) levels were linked to better global cognitive performance, suggesting a potential compensatory role.

Conclusions:

  • Specific PAFs show associations with global cognitive performance in CAD patients.
  • These associations appear stronger in CAD patients with major depression.
  • Further research is needed to confirm these preliminary findings and elucidate the role of PAFs in cognitive decline within this population.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
756
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
919
Cognitive Therapy01:25

Cognitive Therapy

Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.5K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493